Ishikawa K - Search Results

1

A Novel Anti-CD44 Variant 3 Monoclonal Antibody C₄₄Mab-6 Was Established for Multiple Applications.

Suzuki H, Kitamura K, Goto N, Ishikawa K, Ouchida T, Tanaka T, Kaneko MK, Kato Y. Suzuki H, et al. Among authors: ishikawa k. Int J Mol Sci. 2023 May 7;24(9):8411. doi: 10.3390/ijms24098411. Int J Mol Sci. 2023. PMID: 37176118 Free PMC article.

2

EMab-300 Detects Mouse Epidermal Growth Factor Receptor-Expressing Cancer Cell Lines in Flow Cytometry.

Goto N, Suzuki H, Tanaka T, Ishikawa K, Ouchida T, Kaneko MK, Kato Y. Goto N, et al. Among authors: ishikawa k. Antibodies (Basel). 2023 Jun 21;12(3):42. doi: 10.3390/antib12030042. Antibodies (Basel). 2023. PMID: 37489364 Free PMC article.

3

Establishment of a Novel Anti-CD44 Variant 10 Monoclonal Antibody C₄₄Mab-18 for Immunohistochemical Analysis against Oral Squamous Cell Carcinomas.

Ishikawa K, Suzuki H, Kaneko MK, Kato Y. Ishikawa K, et al. Curr Issues Mol Biol. 2023 Jun 21;45(7):5248-5262. doi: 10.3390/cimb45070333. Curr Issues Mol Biol. 2023. PMID: 37504249 Free PMC article.

4

[Amerlex TSH].

Masaka M, Ishikawa K, Ogawa M, Yoshimi T, Kaneko M. Masaka M, et al. Among authors: ishikawa k. Radioisotopes. 1983 May;32(5):241-4. Radioisotopes. 1983. PMID: 6622759 Japanese. No abstract available.

5

[Fundamental studies of IgE kit "Daiichi" S].

Masaka M, Satoh A, Yoshimi T, Ishikawa K, Kaneko M. Masaka M, et al. Among authors: ishikawa k. Kaku Igaku. 1985 Mar;22(3):399-405. Kaku Igaku. 1985. PMID: 4021207 Japanese. No abstract available.

6

In vivo trial of bioresorbable mesh cages contained bone graft granules in rabbit femoral bone defects.

Yanagisawa T, Hayashi K, Tsuchiya A, Kishida R, Ishikawa K. Yanagisawa T, et al. Among authors: ishikawa k. Sci Rep. 2024 May 30;14(1):12449. doi: 10.1038/s41598-024-63067-y. Sci Rep. 2024. PMID: 38816454

7

An NLR paralog Pit2 generated from tandem duplication of Pit1 fine-tunes Pit1 localization and function.

Li Y, Wang Q, Jia H, Ishikawa K, Kosami KI, Ueba T, Tsujimoto A, Yamanaka M, Yabumoto Y, Miki D, Sasaki E, Fukao Y, Fujiwara M, Kaneko-Kawano T, Tan L, Kojima C, Wing RA, Sebastian A, Nishimura H, Fukada F, Niu Q, Shimizu M, Yoshida K, Terauchi R, Shimamoto K, Kawano Y. Li Y, et al. Among authors: ishikawa k. Nat Commun. 2024 May 30;15(1):4610. doi: 10.1038/s41467-024-48943-5. Nat Commun. 2024. PMID: 38816417

8

Activation of the Wnt/β-catenin signaling pathway and CTNNB1 mutations in canine intestinal epithelial proliferative lesions.

Ishikawa K, Chambers JK, Uchida K. Ishikawa K, et al. J Vet Med Sci. 2024 May 29. doi: 10.1292/jvms.24-0125. Online ahead of print. J Vet Med Sci. 2024. PMID: 38811188

9

Systematic Review of Beta-Lactam vs. Beta-Lactam plus Aminoglycoside Combination Therapy in Neutropenic Cancer Patients.

Ishikawa K, Nakamura T, Kawai F, Ota E, Mori N. Ishikawa K, et al. Cancers (Basel). 2024 May 19;16(10):1934. doi: 10.3390/cancers16101934. Cancers (Basel). 2024. PMID: 38792012 Free article. Review.

10

A case of pediatric Perthes' disease with unexplained hyperlactatemia at the time of initial surgery and anesthetic management with remimazolam for the subsequent surgery.

Ishikawa K, Hiroki T, Ito S, Aso C, Saito S. Ishikawa K, et al. JA Clin Rep. 2024 May 24;10(1):31. doi: 10.1186/s40981-024-00715-2. JA Clin Rep. 2024. PMID: 38787500 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,386 results

Search Page